Cancer Data Explorer
An interactive web-based platform presenting Queensland cancer statistics. Explore cancer incidence, mortality, survival, projections and prevalence.
Cancer Alliance Queensland
Access and view our extensive list of cancer publications including journal articles, quality indices, and more.
MDTs & QOOL
See how QOOL can help with your MDT.
CAQ Strategic Plan 2024-26
Our 2024-26 strategic plan outlines key strategies aimed at realising our goals of engagement, leadership and impact. We're committed to achieving measurable success and providing clear insights into how the healthcare system performs, to help improve cancer care delivery and patient outcomes for all Queenslanders with cancer.
This document outlines the vision, strategy and next steps in shaping the future of Cancer Alliance Queensland.
Rare Cancer Care & Research Fund
The Rare Cancer Care & Research Fund was established in October 2022 through the generosity and foresight of two patients of the Sunshine Coast Hospital and Health Service. In essence, the Fund helps provide patient-centred care and research initiatives that advance the provision of care for people with rare forms of cancer. Funds will not be applied to initiatives for those forms of cancer for which significant government and private funding is already available.
The Fund operates under the auspice of Wishlist (Sunshine Coast Health Foundation) in collaboration with Sunshine Coast University Hospital (SCUH), particularly the Medical Oncology Unit and the Research Governance and Development Unit. Collaborations are also in place with key external parties including Cancer Alliance Queensland and Australian Families 4 Genomics.
Queensland AML Quality Index 2012-2021
The Queensland Acute Myeloid Leukaemia Quality Index has been developed through extensive consultation with the Haematology Sub-committee, comprising of expert haematologists from across Queensland. This report is the first of its kind and aims to provide not only an epidemiological overview but also an analysis of key quality indicators. The retrospective data used in this Index is useful for benchmarking and establishing baseline AML treatment rates for Queensland. The Index reports on 10 years of data from 2012-2021, and includes outcomes such as multidisciplinary team review, FLT3 testing, treatment patterns, 30-day mortality and survival.
Queensland Brain Cancer Quality Index
The Queensland Brain Cancer Quality Index is the first brain cancer report in more than a decade and the most detailed brain cancer report published to date by Cancer Alliance Queensland. This Index is useful for benchmarking and establishing baseline brain cancer management patterns for Queensland. The indicators cover multiple stages of the patient journey including diagnosis, surgery, radiation and survival with specific indicators for particular pathological subtypes of brain cancer. The report highlights that over the two five-year periods increased access to radiation therapy has seen more Queenslanders receiving radiation therapy for their brain cancer diagnosis and more Queenslanders receiving their radiation therapy within appropriate time frames.